GLP-1 RECEPTOR AGONISTS BEYOND OBESITY: EXPANDING HORIZONS IN CARDIOMETABOLIC, RENAL, AND NEUROLOGICAL DISEASE. (2026). International Journal of Medical Sciences, 6(4), 849-855. https://doi.org/10.55640/